Brokerages Anticipate CryoPort Inc (NASDAQ:CYRX) Will Post Earnings of -$0.08 Per Share

Share on StockTwits

Brokerages expect CryoPort Inc (NASDAQ:CYRX) to announce ($0.08) earnings per share for the current quarter, according to Zacks Investment Research. Four analysts have made estimates for CryoPort’s earnings. The highest EPS estimate is ($0.07) and the lowest is ($0.08). CryoPort posted earnings per share of ($0.09) in the same quarter last year, which would suggest a positive year-over-year growth rate of 11.1%. The company is expected to announce its next earnings results on Thursday, August 8th.

According to Zacks, analysts expect that CryoPort will report full-year earnings of ($0.29) per share for the current year, with EPS estimates ranging from ($0.32) to ($0.26). For the next year, analysts expect that the company will post earnings of ($0.18) per share, with EPS estimates ranging from ($0.24) to ($0.11). Zacks Investment Research’s earnings per share averages are a mean average based on a survey of sell-side research analysts that cover CryoPort.

CryoPort (NASDAQ:CYRX) last posted its quarterly earnings data on Thursday, May 2nd. The consumer goods maker reported ($0.08) earnings per share for the quarter, meeting the Thomson Reuters’ consensus estimate of ($0.08). CryoPort had a negative return on equity of 28.30% and a negative net margin of 41.61%. The business had revenue of $6.65 million during the quarter, compared to the consensus estimate of $6.56 million. During the same period in the prior year, the company earned ($0.10) earnings per share. The company’s revenue was up 65.4% compared to the same quarter last year.

Separately, BidaskClub cut CryoPort from a “strong-buy” rating to a “buy” rating in a research report on Tuesday. Five investment analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company’s stock. CryoPort has an average rating of “Buy” and an average target price of $19.75.

NASDAQ:CYRX opened at $17.87 on Tuesday. The firm has a market capitalization of $550.02 million, a price-to-earnings ratio of -57.65 and a beta of 0.85. The company has a debt-to-equity ratio of 0.42, a current ratio of 11.57 and a quick ratio of 11.52. CryoPort has a 1 year low of $8.28 and a 1 year high of $18.99.

Several hedge funds have recently made changes to their positions in CYRX. FMR LLC acquired a new stake in shares of CryoPort during the fourth quarter valued at $4,556,000. Essex Investment Management Co. LLC purchased a new stake in shares of CryoPort during the 4th quarter valued at about $2,339,000. Pier Capital LLC increased its holdings in CryoPort by 48.6% during the 1st quarter. Pier Capital LLC now owns 505,334 shares of the consumer goods maker’s stock worth $6,529,000 after purchasing an additional 165,229 shares during the last quarter. BlackRock Inc. increased its holdings in CryoPort by 8.9% during the 1st quarter. BlackRock Inc. now owns 1,913,047 shares of the consumer goods maker’s stock worth $24,717,000 after purchasing an additional 156,881 shares during the last quarter. Finally, Roubaix Capital LLC purchased a new stake in CryoPort during the 1st quarter worth approximately $1,679,000. Institutional investors and hedge funds own 53.20% of the company’s stock.

CryoPort Company Profile

CryoPort, Inc engages in the provision of logistics solutions to the life science industry. It also provides logistics solutions for biologic materials such as immunotherapies, stem cells, CAR-T cells, and reproductive cells for clients worldwide, including points-of-care, clinical research organizations central laboratories, biopharmaceuticals, contract manufacturing, health centers, and university researchers.

Featured Article: Why does a company issue an IPO?

Get a free copy of the Zacks research report on CryoPort (CYRX)

For more information about research offerings from Zacks Investment Research, visit

Earnings History and Estimates for CryoPort (NASDAQ:CYRX)

Receive News & Ratings for CryoPort Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CryoPort and related companies with's FREE daily email newsletter.